Skip to content

Review-State-Aware Comparison

Amazonian Yellow Cacao vs Black Caraway Seed

An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.

This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.

Amazonian Yellow Cacao
Black Caraway Seed
Category
Seed
Seed
Public Score
10/10 (validated)
10/10 (validated)
Screened PMIDs
—
—
Entity Type
Compound
Compound
Overview
Amazonian Yellow Cacao seeds are rich in the flavanol (−)-epicatechin, oligomeric procyanidins (B1 and B2), and the methylxanthine theobromine, which together activate the PI3K/Akt/eNOS signaling cascade to increase nitric oxide bioavailability, support vasodilation, and reduce arterial stiffness. While no PubMed-indexed studies investigate this specific cultivar by name, its principal bioactives are pharmacologically identical to those validated in large-scale cocoa flavanol trials—including the COSMOS trial (PMID: 36325643)—which demonstrated significant cardiovascular and cognitive benefits with daily flavanol intake of 500–1,000 mg.
Black caraway seed (Nigella sativa) derives its primary therapeutic effects from thymoquinone (30–48% of essential oil), which inhibits NF-κB signaling to suppress pro-inflammatory cytokines TNF-α, IL-6, and IL-1β while exhibiting potent antioxidant activity (IC50 ~0.017 mg/mL, DPPH assay) (PMID 34073784; PMID 39807848). A comprehensive 2024 review in the International Journal of Molecular Sciences confirmed broad-spectrum pharmacological properties including immunomodulatory, antidiabetic, hepatoprotective, antimicrobial, and anticancer effects supported by in vitro, animal, and human clinical trial evidence (PMID 39769174).
Dosage
Withheld: no dosage-supported approval.
Withheld: no dosage-supported approval.

Human-Reviewed Benefit Text

Amazonian Yellow Cacao

Enhances cognitive function and mood through theobromine and flavonoids that optimize neurotransmitter activity
Supports cardiovascular and circulatory health by promoting nitric oxide production and reducing arterial stiffness
Provides potent antioxidant and cellular protection with catechins and epicatechins that neutralize free radicals
Delivers sustained energy and endurance via theobromine, increasing oxygenation without overstimulation
Promotes gut and digestive health through prebiotic fibers and polyphenols that support microbiome diversity

Black Caraway Seed

Strengthens immune function and protects against oxidative stress through thymoquinone and other antioxidants
Reduces systemic inflammation and alleviates pain via the actions of thymoquinone and essential fatty acids
Supports respiratory health by easing symptoms associated with asthma, bronchitis, and congestion
Promotes digestive health, enhancing gut motility and providing relief from bloating and indigestion
Enhances skin hydration and supports collagen regeneration through its essential fatty acids and Vitamin E content
Supports metabolic health and blood sugar regulation by improving insulin sensitivity

Human-Reviewed Mechanism Text

Amazonian Yellow Cacao

The principal flavanol (−)-epicatechin and oligomeric procyanidins B1 and B2 in Amazonian Yellow Cacao activate endothelial nitric oxide synthase (eNOS) by promoting phosphorylation at serine-1177 (Ser1177) through the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling cascade, thereby increasing nitric oxide (NO) bioavailability, inducing vasodilation, and reducing systemic vascular resistance. Simultaneously, these flavanols scavenge reactive oxygen species (ROS) via direct electron donation and upregulate endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GPx) through activation of the Nrf2/ARE (nuclear factor erythroid 2–related factor 2/antioxidant response element) pathway. Theobromine, the predominant methylxanthine in cacao, acts as a non-selective adenosine receptor (A1/A2A) antagonist and a mild phosphodiesterase (PDE) inhibitor, sustaining cyclic AMP (cAMP) levels to promote smooth muscle relaxation, bronchodilation, and gentle central nervous system stimulation without the jitteriness associated with caffeine. In the gut, unabsorbed procyanidins are catabolized by colonic microbiota into phenylvalerolactones and phenylvaleric acids, which may exert prebiotic-like effects by selectively promoting the growth of Bifidobacterium and Lactobacillus species.

Black Caraway Seed

Thymoquinone, the principal bioactive constituent (30–48% of Nigella sativa essential oil), exerts anti-inflammatory effects primarily by inhibiting the NF-κB signaling cascade, thereby downregulating transcription of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, as well as suppressing cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and matrix metalloproteinases (MMPs) (PMID 34073784; PMID 39769174). Its antioxidant mechanism involves direct scavenging of superoxide anions and hydroxyl radicals, upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), and preservation of intracellular glutathione (GSH) levels through Nrf2 pathway activation (PMID 39807848). Thymoquinone also modulates the PI3K/Akt/mTOR and MAPK/ERK pathways, contributing to its antiproliferative and pro-apoptotic effects in cancer cell lines, while simultaneously activating AMPK signaling to improve insulin sensitivity and hepatic glucose metabolism (PMID 34073784; PMID 24111621). Additional bioactive components—thymohydroquinone, thymol, carvacrol, and α-hederin—contribute synergistically to antimicrobial activity by disrupting bacterial cell membrane integrity (PMID 23646296).

Human-Reviewed Safety Text

Amazonian Yellow Cacao:

Amazonian Yellow Cacao seed consumption is generally recognized as safe at dietary doses, though its theobromine and trace caffeine content may cause insomnia, tachycardia, or gastrointestinal distress in sensitive individuals at high intakes (>40 g dark chocolate equivalent per day). Theobromine and cocoa flavanols may potentiate the effects of anticoagulant and antiplatelet medications (e.g., warfarin, aspirin, clopidogrel) by inhibiting platelet aggregation through NO-mediated pathways and thromboxane A2 suppression; patients on such medications should consult their physician before supplementing. Cacao flavanols have demonstrated mild inhibition of cytochrome P450 enzymes CYP1A2 and CYP3A4 in vitro, which could theoretically alter the metabolism of drugs processed by these pathways (e.g., theophylline, certain statins, benzodiazepines), though clinically significant interactions at normal dietary doses have not been confirmed. Individuals with gastroesophageal reflux disease (GERD), migraine susceptibility, or oxalate-sensitive kidney conditions should exercise caution, as cacao contains oxalic acid and tyramine-related amines that may exacerbate these conditions.

Black Caraway Seed:

Nigella sativa is generally recognized as safe at culinary doses (1–3 g seed/day) and supplemental doses up to 2–3 g/day or 200–600 mg thymoquinone-standardized oil for up to 12 weeks in clinical trials, though higher doses have been associated with gastrointestinal discomfort, nausea, and contact dermatitis in sensitive individuals (PMID 30000936; PMID 34073784). Thymoquinone has demonstrated inhibition of CYP3A4 and CYP2D6 in preclinical models, raising the potential for interactions with substrates of these enzymes including cyclosporine, warfarin, and certain antihypertensive and antidiabetic medications—concurrent use may potentiate hypoglycemic or hypotensive effects (PMID 39769174; PMID 30000936). Pregnant and breastfeeding women should avoid therapeutic doses, as uterotonic effects have been observed in animal studies; individuals scheduled for surgery should discontinue use at least two weeks prior due to potential antiplatelet activity (PMID 34073784). Hepatotoxicity has been reported in rare cases at very high doses, and liver function should be monitored during prolonged high-dose supplementation (PMID 30000936).

Comparison summary

This automated view does not establish that either Amazonian Yellow Cacao or Black Caraway Seed is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.

Frequently Asked Questions

Is Amazonian Yellow Cacao or Black Caraway Seed better?

Amazonian Yellow Cacao and Black Caraway Seed have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.

Can you take Amazonian Yellow Cacao and Black Caraway Seed together?

No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.

What is the main difference between Amazonian Yellow Cacao and Black Caraway Seed?

Amazonian Yellow Cacao is categorized as seed (Compound), while Black Caraway Seed is categorized as seed (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.